New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
ACUTE DYSTONIA DURING FIXED-DOSE NEUROLEPTIC TREATMENT
ACUTE DYSTONIA DURING FIXED-DOSE NEUROLEPTIC TREATMENT JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY Singh, H., Levinson, D. F., Simpson, G. M., Lo, E. S., FRIEDMAN, E. 1990; 10 (6): 389-396Abstract
Eighty-six patients with acute psychotic exacerbations were treated with fixed dosage regimens of oral fluphenazine up to 10-30 mg/day in randomized, double-blind studies. Dystonic reactions occurred in 33.8% of the subjects at risk. Of these, 58% occurred by the third day, 88% by the fourth day, and 100% by the ninth day of treatment; most occurred later in the interdose interval. Significant predictors of dystonic reactions were higher fluphenazine mg/kg dosage and younger age. There was a trend toward a lower risk of dystonia in patients who received amobarbital sodium for agitation. Results are discussed in relation to possible mechanisms of neuroleptic-induced dystonia.
View details for Web of Science ID A1990EN64100003
View details for PubMedID 2286708